Somavert 20mg for subcutaneous injection, manufactured by Pfizer, contains Pegvisomant (genetical recombination). This growth hormone receptor antagonist is used to treat acromegaly by blocking the effects of growth hormone. It has a YJ code of 2499409D3025 and a standard of 20 mg/bottle (with dissolving liquid).
Somavert 20mg for subcutaneous injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →